An open label, multi-cohort, multi-center phase II study evaluating the efficacy and safety of lacutamab (IPH4102) alone or in combination with chemotherapy in patients with advanced t-cell lymphoma

Clinical Trial Name: IPH4102-201 / TELLOMAK study

Clinical Trial Description:

Read more

Naloxone Hydrochloride - Study

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Purpose

Read more

TTI-621 - Study

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Brief Summary

Multicenter, open-label, phase 1a/1b trial of TTI-621 in subjects with relapsed or refractory hematologic malignancies and selected solid tumors.

Read more

Treatment Centers and Clinical Trials

Location

Treatments/Services

Type

OhioHealth Physician Group - Hematology/Oncology

ROCHESTER SKIN LYMPHOMA MEDICAL GROUP, PLLC

Rush University Medical Center

The University of Kansas Hospital

The Warren Alpert Medical School of Brown University, Department of Dermatology

Seattle Cancer Care Alliance

Tulane University School of Medicine

University Dermatology Consultants, Inc.

University Hospitals of Cleveland

University of Alabama Medical Center

University of California, San Francisco

University of Iowa Hospitals & Clinics

University of North Carolina Medical Center

University of Pittsburgh Medical Center

University of Rochester - Wilmot Cancer Institute

University of Texas Southwestern Medical Center

University of Virginia-Emily Couric Clinical Cancer Center

University of Wisconsin - Madison

Vanderbilt University Medical Center

Wake Forest Baptist Health

Winship Cancer Institute - Emory University

Mayo Clinic - Arizona Campus

Cleveland Clinic

Clinical Cancer Center, Froedtert Hospital

Saint Louis University Cancer Center

Washington University Medical Center - Siteman Cancer Center

The Dermatology Clinic at University of Minnesota

Henry Ford Medical Center - Cutaneous T-cell Lymphoma Clinic

University of Michigan Medical Center

Northwestern Medicine

University of Chicago

Yale University School of Medicine

Penn Cutaneous Lymphoma Program

Jefferson Cutaneous Lymphoma Clinic

Boston Medical Center - Cutaneous Oncology Program

Center for Cutaneous Oncology at Dana Farber/Brigham and Women's Cancer Center

Beth Israel Medical Center

Massachusetts General Hospital Cancer Center

Virginia Commonwealth University Medical Center

INOVA Melanoma and Skin Oncology Center

Dartmouth-Hitchcock Norris Cotton Cancer Center

Columbia University Irving Medical Center - Cutaneous Lymphoma Center

NYU Grossman School of Medicine

University of Texas MD Anderson Cancer Center

Moffitt Cancer Center

Cleveland Clinic - Indian River Hospital

Miami Cancer Institute BHSF

Levine Cancer Institute

Duke Cutaneous T-Cell Lymphoma Clinic and Research Center

UCHealth - University of Colorado Cancer Center - Anschutz

Huntsman Cancer Institute

Stanford Medical Center (Multidisciplinary Cutaneous Lymphoma Clinic)

Oregon Health & Science University (OHSU)

GW Cancer Center

Medical University of South Carolina

John Hopkins Dermatology

OU Physicians

City of Hope National Medical Center

Chao Family Comprehensive Cancer Center

Peter MacCallum Cancer Centre

Westmead Hospital - University of Sydney

Medical University of Graz

Medical University of Vienna

Hôtel-Dieu - CHU de Nantes

Helsinki University Hospital

Hospital Dresden-Friedrichstadt

Charité University of Medicine Berlin - Skin Cancer Center

Skin Cancer Center - HELIOS Klinikum Krefeld

Rabin Medical Center

Rambam Medical Center

Spedali Civili di Brescia

Cutaneous Lymphoma Multidisciplinary Clinic - Lisbon

Friedrich Schiller University - Hospital Jena

University Medical Centre - Mannheim

University of Essen - Department of Dermatology

Semmelweis Medical School